We will also further explore the deeper mechanism by which ATRA and TAM can synergistically treat ERα-positive ovarian cancer, which can provide some new ideas and strategies for the clinical treatment of ovarian cancer combined drugs. Here, ESR1 is linked to ovarian cancer.